The overall objective of the proposed research is to understand mechanisms of 1) neural reorganization after insults such as stroke, and 2) host-graft interactions after transplantation, a potential future therapeutic approach to stroke. Specifically, the focus of this project is on the role of neural activity in the reorganizational changes following injury and transplantation. Cerebellar cultures will be chronically exposed during and after treatment with cytosine arabinoside to tetrodotoxin, to block all electrical activity, and to picrotoxin, to enhance the normally present cortical spontaneous activity. The cultures will be monitored by light and electron microscopy for possible alterations of the reorganizational changes consequent to cytosine arabinoside induced granule cell depletion and glial inhibition. These include 1) Purkinje cell recurrent axon collateral sprouting, 2) enhanced Purkinje cell survival, 3) hyperinnervation of Purkinje cell somata by sprouted collaterals, and formation of heterotypical recurrent axon collateral-Purkinje cell dendritic spine synapses. Cytosine arabinoside treated cerebellar cultures will similarly be exposed to tetrodotoxin and picrotoxin immediately after transplantation with granule cells and glia. These transplantation, including reduction of sprouted collaterals and of excess Purkinje cells, astrocytic stripping of excess axosomatic synapses, and the formation of parallel fiber-Purkinje cell dendritic spine synapses. After definition of the ultrastructural characteristics of catecholaminergic terminals in cerebellar cultures with incorporated locus coeruleus, as well as cytosine arabinoside treated coeruleocerebellar cultures and transplanted cytosine arabinoside treated coeruleocerebellar cultures, such cultures will be similarly exposed to tetrodotoxin and picrotoxin, and similarly monitored to determine if the effects of neural activity are different with regard to catecholaminergic axons as compared with other axons.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Seil, Fredrick J (2014) The changeable nervous system: studies on neuroplasticity in cerebellar cultures. Neurosci Biobehav Rev 45:212-32
Clark, W M; Hazel, J S; Coull, B M (1995) Lazaroids. CNS pharmacology and current research. Drugs 50:971-83
Clark, W M; Lauten, J D; Lessov, N et al. (1995) The influence of antiadhesion therapies on leukocyte subset accumulation in central nervous system ischemia in rats. J Mol Neurosci 6:43-50
Clark, W M; Lauten, J D; Lessov, N et al. (1995) Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol 26:213-30
Clark, W M; Hotan, T; Lauten, J D et al. (1994) Therapeutic efficacy of tirilazad in experimental multiple cerebral emboli: a randomized, controlled trial. Crit Care Med 22:1161-6
Clark, W M; Calcagno, F A; Gabler, W L et al. (1994) Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment. Stroke 25:1411-5;discussion 1416
Clark, W M; Coull, B M; Briley, D P et al. (1993) Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J Neuroimmunol 44:123-5
Coull, B M; Clark, W M (1993) Abnormalities of hemostasis in ischemic stroke. Med Clin North Am 77:77-94
Clark, W M; Coull, B M; Beamer, N B (1993) Need for treatment of elevated plasma fibrinogen levels in cerebrovascular disease. Heart Dis Stroke 2:503-6
Coull, B M; Levine, S R; Brey, R L (1992) The role of antiphospholipid antibodies in stroke. Neurol Clin 10:125-43

Showing the most recent 10 out of 12 publications